Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Background The impact of pulmonary embolism response teams (PERTs) on treatment
choice and outcomes of patients with acute pulmonary embolism (PE) is still uncertain …

The coexistence of coronavirus disease 2019 (COVID-19) and pulmonary embolism (PE),
two life-threatening illnesses, in the same patient presents a unique challenge. Guidelines …

Objectives: Identify the etiology of acute pulmonary embolism. Describe the pertinent
findings for the diagnosis of patients with acute pulmonary embolism. Explain the …

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic due to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has challenged health-care systems and …

Pulmonary embolism (PE) is a major source of morbidity and mortality. The presentation of
acute PE varies, ranging from few or no symptoms to sudden death. Patient outcome …

Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary,
multispecialty team of experts in the care of highly complex symptomatic acute pulmonary …

Rationale: Acute pulmonary embolism is a leading cause of cardiovascular death. There are
limited data on the national mortality trends from pulmonary embolism. Understanding these …

Background Isolated pulmonary embolism (PE) appears to be associated with a specific
clinical profile and sequelae compared to deep vein thrombosis (DVT)-associated PE. The …

Background Optimal management of acute pulmonary embolism requires expertise offered
by multiple subspecialties. As such, pulmonary embolism response teams (PERTs) have …